Anavex Life Sciences Corp.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 65 | 0.0% | 18,209 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 162 | 0.0% | 18,209 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 168 | 0.0% | 18,209 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 156 | 0.0% | 18,209 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 196 | 0.0% | 18,209 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 103 | 0.0% | 18,209 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 77 | 0.0% | 18,209 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 149 | 0.0% | 29,301 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 273 | 0.0% | 29,321 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 175 | 0.0% | 26,651 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 215 | 0.0% | 26,439 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 337 | 0.0% | 39,296 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 448 | 0.0% | 48,420 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 456 | 0.0% | 44,219 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 441 | 0.0% | 44,089 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 544 | 0.0% | 44,168 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 766 | 0.0% | 44,148 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 794 | 0.0% | 44,252 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 1,227 | 0.0% | 53,674 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 637 | 0.0% | 42,600 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 170 | 0.0% | 31,400 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 126 | 0.0% | 27,800 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 137 | 0.0% | 27,800 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 88 | 0.0% | 27,800 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 72 | 0.0% | 27,800 | 12/31/2019 |